AGN - Allergan plc

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 551.91B
Enterprise Value 373.2B
Trailing P/E N/A
Forward P/E 19.36
PEG Ratio (5 yr expected) 12.86
Price/Sales (ttm)3.31
Price/Book (mrq)0.87
Enterprise Value/Revenue 34.67
Enterprise Value/EBITDA 610.17

Trading Information

Stock Price History

Beta (3Y Monthly) 1.95
52-Week Change 3-18.04%
S&P500 52-Week Change 3-0.33%
52 Week High 3197.00
52 Week Low 3114.27
50-Day Moving Average 3162.56
200-Day Moving Average 3145.57

Share Statistics

Avg Vol (3 month) 34.91M
Avg Vol (10 day) 34.11M
Shares Outstanding 5327.8M
Float 326.96M
% Held by Insiders 10.30%
% Held by Institutions 188.91%
Shares Short (Jul 31, 2019) 45.93M
Short Ratio (Jul 31, 2019) 41.18
Short % of Float (Jul 31, 2019) 41.80%
Short % of Shares Outstanding (Jul 31, 2019) 41.81%
Shares Short (prior month Jun 28, 2019) 44.67M

Dividends & Splits

Forward Annual Dividend Rate 42.96
Forward Annual Dividend Yield 41.88%
Trailing Annual Dividend Rate 32.92
Trailing Annual Dividend Yield 31.87%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3Sep 13, 2019
Ex-Dividend Date 4Aug 12, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Oct 30, 1997

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -54.25%
Operating Margin (ttm)6.71%

Management Effectiveness

Return on Assets (ttm)0.64%
Return on Equity (ttm)-12.97%

Income Statement

Revenue (ttm)15.68B
Revenue Per Share (ttm)47.01
Quarterly Revenue Growth (yoy)-0.80%
Gross Profit (ttm)13.52B
EBITDA 7.19B
Net Income Avi to Common (ttm)-8.5B
Diluted EPS (ttm)-25.50
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.97B
Total Cash Per Share (mrq)6.02
Total Debt (mrq)23.24B
Total Debt/Equity (mrq)38.93
Current Ratio (mrq)1.03
Book Value Per Share (mrq)181.99

Cash Flow Statement

Operating Cash Flow (ttm)5.59B
Levered Free Cash Flow (ttm)4.3B